i am not sure whether i would call it good prices. if we dont get a licensing deal this quarter this company is toast and all creditibility with MD will be lost. next CR will be lot of pain due to burn rate of biotech stocks
options expiry date is drawing closer would be huge boost to the balance sheet if MD can deliver and avoid another CR anytime soon.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $1.64K | 774.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 23189357 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 5450580 | 12 |
View Market Depth
| Last trade - 15.13pm 16/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |